LMR Partners LLP

Position in ELAN — Elanco Animal Health Inc

CIK 1578621 LONDON, X0

Position in ELAN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$32,865,079

+$4,978,063 QoQ

Shares Held

1,335,436

+14.6% QoQ

Ownership

0.267%

of shares outstanding

% of Portfolio

0.38%

of 13F equity value

Holder Rank

#57

of 518 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 97% Shared 3% None 0%

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $64,073,206 across 5 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (51.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc This page	1,335,436	$32,865,079
2	TEVA	Teva Pharmaceutical Industries Ltd	582,275	$19,727,477
3	NBIX	Neurocrine Biosciences Inc	55,545	$9,361,553
4	UTHR	UNITED THERAPEUTICS Corp	3,911	$2,119,097
5			1,607,177	$0

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,865,079	1,335,436	+14.6%	Shares	Sole	2026-08-14
2026-03-31	$27,887,016	1,165,358	+248.4%	Shares	Sole	2026-05-15
2024-09-30	$4,914,231	334,529	-49.5%	Shares	Sole	2024-11-07
2024-06-30	$9,557,479	662,334	+67.6%	Shares	Other	2024-08-14
2024-03-31	$6,434,735	395,254	-2.9%	Shares	Sole	2024-05-15
2023-12-31	$6,066,818	407,169	+854.0%	Shares	Sole	2024-02-14
2023-06-30	$429,340	42,678	-73.7%	Shares	Sole	2023-08-14
2020-12-31	$4,983,875	162,500	-60.6%	Shares	Sole	2021-02-16
2020-06-30	$8,601,988	412,792	+8.8%	Shares	Sole	2020-08-14
2020-03-31	$8,492,504	379,299	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.